Clinical Trials on CNV in United Kingdom
Total 2150 results
-
Duke UniversityUnited States Department of DefenseCompletedCNS Oxygen Toxicity, Ketogenic DietUnited States
-
NYU Langone HealthRecruitingCOVID-19 | SARS CoV 2 InfectionUnited States
-
Duke UniversityTerminated
-
Rutgers, The State University of New JerseyNational Institute of Dental and Craniofacial Research (NIDCR)Completed
-
University of Missouri-ColumbiaCompletedSARS-CoV 2 | ARDSUnited States
-
National Institute of Allergy and Infectious Diseases...RecruitingCMV | HPV | EBV | HSV | VZVUnited States
-
Massachusetts General HospitalCompletedIn Utero SARS-CoV-2 ExposureUnited States
-
NYU Langone HealthRecruitingNeuropsychiatric Post-Acute Sequelae of SARS-CoV-2 InfectionUnited States
-
AstraZenecaCompletedCOVID-19 | SARS-CoV-2United Kingdom, Brazil, South Africa, Poland
-
Merck Sharp & Dohme LLCCompletedCytomegalovirus (CMV) InfectionsUnited States, Australia, Canada, Finland, Israel, Russian Federation, Spain
-
Rutgers, The State University of New JerseyUniversity Hospital - Newark, NJNo longer availableCOVID-19 | SARS-CoV 2 | SARS-CoV InfectionUnited States
-
ModernaTX, Inc.CompletedInfluenza | SARS-CoV-2 | RSVUnited Kingdom, Australia, United States
-
GlaxoSmithKlineCureVacCompleted
-
University of MinnesotaWithdrawnPost-acute Sequelae SARS-CoV-2 Infection (PASC)United States
-
EMD SeronoCompletedMultiple SclerosisUnited States, Australia, France, Italy, Turkey, United Kingdom, Austria, Germany, Israel, Argentina, Norway, Spain
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedCancer SurvivorUnited States
-
AmgenCompletedAdvanced Non CNS TumorsUnited States, Belgium, Spain, France, Canada, Italy, Switzerland
-
Astellas Pharma Global Development, Inc.VicalCompletedKidney Transplantation Cytomegalovirus (CMV) Negative RecipientsUnited States, Australia, Canada, France, Germany, Spain
-
Mitsubishi Tanabe Pharma CorporationCompletedRelapsing-remitting Multiple SclerosisCroatia, Bulgaria, Czech Republic, Italy, Russian Federation, Spain, United Kingdom, Germany, Lithuania, Poland, Belgium, Hungary, Serbia, Finland, Ukraine, Switzerland, Canada, Turkey
-
University of PittsburghCompleted
-
University of UtahCompletedSARS CoV-2 InfectionUnited States
-
Novartis PharmaceuticalsCompletedMultiple Sclerosis | RRMSSpain, Czechia, Germany, Australia, Italy, Switzerland, Denmark, United States, United Kingdom, Canada, Netherlands, Poland
-
ModernaTX, Inc.Completed
-
Johns Hopkins UniversityEiger BioPharmaceuticalsTerminatedSars-CoV-2 InfectionUnited States
-
TScan Therapeutics, Inc.CompletedIdentify the Viral Epitopes of Memory CD8 T Cells From Individuals That Have Recovered From SARS-CoV-2 Infection | Determine Which SARS-CoV-2 Proteins Are Frequently Recognized by T Cells in Patients With Varying HLA TypesUnited States
-
Mayo ClinicCompletedCytomegalovirus InfectionUnited States
-
ModernaTX, Inc.Completed
-
Grifols Therapeutics LLCCompletedMultiple Sclerosis, Relapsing-RemittingCanada, Israel, United States, Austria, Czech Republic, Germany, Greece, Hungary, Poland, Slovakia, Sweden, United Kingdom
-
Family Health Centers of San DiegoActive, not recruitingChronic Fatigue Syndrome | SARS-CoV-2 Acute Respiratory Disease | Post COVID-19 Condition | Myalgic Encephalomyelitis | Post-acute Sequelae of SARS-COV-2 InfectionUnited States
-
BiogenTerminatedMultiple SclerosisUnited States, Italy, Switzerland, United Kingdom, Czechia, France
-
Hunt Regional Medical CenterRecruitingHypoxia | SARS-CoV-2 | ARDSUnited States
-
University of MinnesotaCompletedCMV Viremia | EBV ViremiaUnited States
-
ModernaTX, Inc.CompletedSARS-CoV-2United States
-
NovavaxCompletedCOVID-19 | SARS-CoV-2 InfectionUnited Kingdom
-
Astellas Pharma Global Development, Inc.CompletedCytomegalovirus (CMV)-Positive Recipients | Allogeneic, Hematopoietic Cell Transplant (HCT)Japan, Korea, Republic of, United States, Canada, Australia, Belgium, France, Germany, Spain, Sweden, Taiwan
-
Johns Hopkins UniversityNational Institute of Allergy and Infectious Diseases (NIAID); United States... and other collaboratorsCompletedSARS-CoV 2United States
-
Children's National Research InstituteRecruitingMedulloblastoma, Childhood | Embryonal Tumor With Multilayered Rosettes | Pineoblastoma | Embryonal Tumor of CNS | Atypical Teratoid/Rhabdoid Tumor of CNSUnited States
-
BayerCompletedRelapsing Remitting Multiple Sclerosis (RRMS)China, Slovakia, France, Germany, Korea, Republic of, Saudi Arabia, Singapore, Sweden, Taiwan, Colombia, Czech Republic, Estonia, Italy, Jordan, Lebanon, Mexico, Slovenia, United Kingdom, Argentina, Bahrain, Egypt, United Arab Emirates and more
-
University of Colorado, DenverRecruitingPost-acute Sequelae of SARS-CoV-2 InfectionUnited States
-
St. Jude Children's Research HospitalNovartis PharmaceuticalsCompletedRecurrent or Refractory Solid Tumors | CNS MalignanciesUnited States
-
NovartisCompletedRelapsing Multiple SclerosisBelgium, Poland, Spain, France, United Kingdom, Guatemala, Canada, Finland, Switzerland
-
Hoffmann-La RocheWithdrawnMultiple SclerosisSpain, United Kingdom, Czech Republic, Canada, Germany, Slovakia, Poland, Bulgaria, Russian Federation
-
Juno Therapeutics, Inc., a Bristol-Myers Squibb...Celgene CorporationRecruitingMultiple SclerosisUnited States, Belgium, France, Germany, Spain, United Kingdom, Italy
-
PfizerCompletedCovid-19 | Immunocompromised | Breakthrough Infection | SARS-COV-2 Infection | SARS-COV-2 | ImmunosuppressedUnited States
-
Everly HealthCompletedSARS-CoV-2 Acute Respiratory DiseaseUnited States
-
ChimerixCompletedCMVUnited States, Belgium, Canada
-
GeneOne Life Science, Inc.TerminatedSARS-CoV 2 | InfectionUnited States
-
Everly HealthCompletedSARS-CoV-2 Acute Respiratory DiseaseUnited States
-
GlaxoSmithKlineCompletedMultiple Sclerosis, Relapsing-RemittingSpain, Bulgaria, Ukraine, United Kingdom, Sweden, Germany, Canada, Czech Republic